Showing 501 - 520 results of 651 for search '"oncology"', query time: 0.11s Refine Results
  1. 501
  2. 502
  3. 503
  4. 504
  5. 505

    A Nomogram for Predicting Overall Survival in Primary Central Nervous System Lymphoma: A Retrospective Study by Ling Y, Miao X, Zhou X, Ma J, Lin Z, Li Q, Zhang M, Ma Y, Chen B

    Published 2025-02-01
    “…Additionally, Kaplan-Meier survival curves were plotted to show the stratification ability of the risk groups.Results: Eastern Cooperative Oncology Group performance status (ECOG-PS), albumin, and two inflammatory biomarkers D-Dimer, and neutrophil-to-lymphocyte ratio (NLR)—were independent predictors of inferior OS. …”
    Get full text
    Article
  6. 506

    Short-term results of laparoscopic and open complete mesocolic excision with D3 lymph node dissection for left-sided colon cancer by P. V. Tsarkov, I. A. Tulina, A. Yu. Kravchenko, A. V. Leont’Yev

    Published 2016-08-01
    “…Morphological scores indicate identical efficacy in achievement of radical treatment for laparoscopic and open techniques from the standpoint of modern oncology principles. However, correct estimation of long-term outcomes require further studies.…”
    Get full text
    Article
  7. 507
  8. 508
  9. 509
  10. 510

    Correlation pain-quality of life in women after being submitted to surgical treatment of breast cancer by Izabela dos Santos Mendes, Sergio Takeshi Tatsukawa de Freitas, Glaucia de Castro Souza, Mariana Cesar Ribeiro dos Reis, Djenifer Queiroz de Souza, Fernanda Pupio Silva Lima, Adriano Oliveira Andrade, Mario Oliveira Lima

    Published 2014-04-01
    “…The sample consisted of 49 women with a mean age of 53.9 ± 8.8 years, treated in Specialized Oncology Centers in the region. There was no significant difference between the pain domains compared to other domains. …”
    Get full text
    Article
  11. 511
  12. 512
  13. 513

    Selective epithelial expression of KRASG12D in the Oncopig pancreas drives ductal proliferation and desmoplasia that is accompanied by an immune response by Carlos P. Jara, Al-Murtadha Al-Gahmi, Audrey Lazenby, Michael A. Hollingsworth, Mark A. Carlson

    Published 2025-02-01
    “…Abstract Pancreatic ductal adenocarcinoma (PDAC) remains a formidable challenge in oncology, characterized by a high mortality rate, largely attributable to delayed diagnosis and the intricacies of its tumor microenvironment. …”
    Get full text
    Article
  14. 514

    The Effects of Adverse Events and Associated Costs on Value-Based Care for Metastatic Pancreatic Ductal Adenocarcinoma by Prachi Bhatt, Jared Hirsch, Paul Cockrum, George Kim, Gabriela Dieguez

    Published 2024-12-01
    “…**Background:** Rising oncology healthcare costs have led to value-based care reimbursement models that coordinate care and improve quality while reducing overall spending. …”
    Get full text
    Article
  15. 515
  16. 516

    Real-World Treatment Patterns in Men with Castration- Resistant Prostate Cancer Receiving Docetaxel by Keith L. Davis, Benjamin Gutierrez, Teresa Zyczynski, James A. Kaye

    Published 2015-01-01
    “…Data were collected by 48 physicians from oncology (patient N=344) and 8 physicians from urology (patient N=50) practices. …”
    Get full text
    Article
  17. 517
  18. 518
  19. 519
  20. 520